J. Thaler

发表

Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.

I. Pabinger, C. Ay, G. Kornek, 2014, Translational research : the journal of laboratory and clinical medicine.

Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.

D. Dunkler, A. Haitel, C. Zielinski, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venous thromboembolism in cancer patients – Risk scores and recent randomised controlled trials

I. Pabinger, C. Ay, J. Thaler, 2012, Thrombosis and Haemostasis.

Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study.

C. Marosi, D. Dunkler, C. Zielinski, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarkers for prediction of venous thromboembolism in cancer.

I. Pabinger, C. Ay, J. Thaler, 2013, Blood.

THROMBOSIS AND HEMOSTASIS Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

D. Lötsch, W. Berger, C. Marosi, 2017 .

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism.

D. Lötsch, W. Berger, C. Marosi, 2017, Blood.

Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

C. Marosi, A. Kaider, W. Scheithauer, 2012, Journal of thrombosis and haemostasis : JTH.

Correction: Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease

M. Mayr, D. Voehringer, M. Rauh, 2018, The Journal of experimental medicine.

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease

M. Mayr, D. Voehringer, M. Rauh, 2017, The Journal of experimental medicine.

Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.

C. Marosi, A. Kaider, J. Hainfellner, 2013, Thrombosis research.

Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants

A. Spittler, A. Berger, I. Pabinger, 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

How I Treat Patients with Hereditary Antithrombin Deficiency.

I. Pabinger, J. Thaler, 2019, Blood.

Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models – two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers

B. Gustorff, J. Thaler, David Hauer, 2011, Expert Opinion on Pharmacotherapy.

Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation

G. Kramer, J. Schmid, B. Moser, 2021, Cancers.

Procoagulant extracellular vesicles in amniotic fluid

P. Altevogt, A. Spittler, B. Jilma, 2017, Translational research : the journal of laboratory and clinical medicine.

Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.

R. Koppensteiner, I. Pabinger, C. Ay, 2014, Thrombosis research.

Circulating procoagulant microparticles in cancer patients

J. Freyssinet, D. Dunkler, C. Zielinski, 2011, Annals of Hematology.

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease

M. Trauner, M. Mandorfer, T. Reiberger, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Toward standardization of assays measuring extracellular vesicle‐associated tissue factor activity

R. Nieuwland, N. Mackman, F. Dignat-George, 2019, Journal of thrombosis and haemostasis : JTH.

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis

N. Mackman, I. Pabinger, C. Ay, 2018, Annals of Hematology.

Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites

R. Nieuwland, M. Trauner, P. Schwabl, 2021, Thrombosis and Haemostasis.

Thrombosis risk and survival in cancer patients with elevated C‐reactive protein

W. Scheithauer, D. Dunkler, C. Zielinski, 2011, Journal of thrombosis and haemostasis : JTH.

Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior

E. Fabian, G. Prager, M. Herac, 2022, Journal of Cancer.

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS)

C. Marosi, D. Dunkler, C. Mannhalter, 2015, Journal of thrombosis and haemostasis : JTH.

Human milk triggers coagulation via tissue factor-exposing extracellular vesicles.

R. Nieuwland, I. Pabinger, A. van Dam, 2020, Blood advances.

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting

J. Wojta, S. Demyanets, L. Mauracher, 2020, Journal of clinical medicine.

Longitudinal analysis of extracellular vesicle-associated tissue factor activity in cancer patients.

A. Kaider, G. Prager, I. Pabinger, 2020, Thrombosis research.

Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings

A. Laggner, B. Jilma, A. Schober, 2014, Thrombosis and Haemostasis.

Coagulation signaling from amniotic fluid to fetal skin

A. Scharrer, R. Nieuwland, C. Ay, 2022, Blood advances.

Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII

R. Nieuwland, I. Pabinger, C. Ay, 2022, Journal of thrombosis and haemostasis : JTH.

Influence of hemoadsorption during cardiopulmonary bypass on blood vesicle count and function

A. Spittler, A. Berger, V. Weber, 2020, Journal of Translational Medicine.

Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia.

W. Sperr, I. Pabinger, C. Ay, 2014, Thrombosis research.

Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)

K. Gleixner, P. Knöbl, I. Pabinger, 2021, Journal of thrombosis and haemostasis : JTH.

Emicizumab for the treatment of acquired hemophilia A.

W. Sperr, K. Gleixner, P. Quehenberger, 2020, Blood.

High D-dimer levels are associated with poor prognosis in cancer patients

O. Wagner, R. Pirker, D. Dunkler, 2012, Haematologica.

Extracellular vesicles, tissue factor, cancer and thrombosis – discussion themes of the ISEV 2014 Educational Day

R. Nieuwland, B. Carter, J. Rak, 2015, Journal of extracellular vesicles.

Extracellular Vesicles in Human Milk

R. Nieuwland, J. Thaler, Yong Hu, 2021, Pharmaceuticals.

Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients

D. Wagner, C. Zielinski, I. Pabinger, 2018, Journal of thrombosis and haemostasis : JTH.

Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer

G. Prager, N. Mackman, I. Pabinger, 2021, Arteriosclerosis, thrombosis, and vascular biology.

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function

A. Ba-Ssalamah, M. Trauner, P. Schwabl, 2018, Wiener klinische Wochenschrift.

Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory protein.

G. Weiss, K. Grünewald, J. Brock, 1997, Biochemical pharmacology.

Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

C. Marosi, G. Ricken, J. Hainfellner, 2018, Journal of thrombosis and haemostasis : JTH.

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.

C. Marosi, A. Kaider, C. Mannhalter, 2014, Neuro-oncology.

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

D. Bauer, M. Trauner, P. Schwabl, 2018, Alimentary pharmacology & therapeutics.

Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study

W. Scheithauer, D. Dunkler, C. Zielinski, 2013, Haematologica.

Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art

I. Pabinger, C. Ay, J. Thaler, 2015, Front. Cardiovasc. Med..

Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia.

I. Pabinger, C. Ay, P. Quehenberger, 2021, Thrombosis research.

Emicizumab for the Treatment of Acquired Hemophilia A: Lessons Learned from 4 very Different Cases

W. Sperr, T. Staudinger, K. Gleixner, 2018, Hämostaseologie.

Estrogen receptor beta and truncated variants enhance the expression of transfected MMP-1 promoter constructs in response to specific mechanical loading

N. Shrive, D. Hart, Y. Achari, 2014, Biology of Sex Differences.

Clinical significance of circulating microparticles for venous thrombo - embolism in cancer patients

I. Pabinger, C. Ay, J. Thaler, 2012, Hämostaseologie.

Androgen receptor dampens tissue factor expression via nuclear factor‐κB and early growth response protein 1

N. Mackman, J. Schmid, B. Moser, 2018, Journal of thrombosis and haemostasis : JTH.

Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery

I. Pabinger, C. Ay, G. Schernthaner, 2016, International Journal of Obesity.

Microparticle‐associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features

A. Kaider, W. Scheithauer, M. Gnant, 2013, European journal of clinical investigation.

Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)

G. Zlabinger, C. Zielinski, I. Pabinger, 2015, Clinical Cancer Research.

Androgen receptor dampens tissue factor expression via NF-κ B and EGR 1

N. Mackman, J. Schmid, B. Moser, 2018 .

Influence of hemoadsorption during cardiopulmonary bypass on blood vesicle count and function

A. Spittler, A. Berger, V. Weber, 2020, Journal of Translational Medicine.

The impact of ABO blood type on VWF and factor VIII levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease

M. Trauner, M. Mandorfer, T. Reiberger, 2019, Zeitschrift für Gastroenterologie.

Plasma Clot Properties in Patients with Pancreatic Cancer

G. Prager, C. Ay, J. Thaler, 2023, Cancers.

Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.

C. Marosi, B. Jilma, I. Pabinger, 2020, Translational research : the journal of laboratory and clinical medicine.